Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H Lund

Showing results (581-590 of 826) with videos related to

Pageof 83
Sort By:
European Journal of Heart Failure|July 22, 2014
Association between cardiovascular vs. non-cardiovascular co-morbidities and outcomes in heart failure with preserved ejection fractionLars H Lund, Erwan Donal, Emmanuel Oger, et al.
Journal of Cardiac Failure|August 27, 2020
Association of Coronary Microvascular Dysfunction With Heart Failure Hospitalizations and Mortality in Heart Failure With Preserved Ejection Fraction: A Follow-up in the PROMIS-HFpEF StudyCamilla Hage, Sara Svedlund, Antti Saraste, et al.
Urology|May 30, 2001
Comparison of the efficacy and safety of finasteride in older versus younger men with benign prostatic hyperplasiaS A Kaplan, H L Holtgrewe, R Bruskewitz, et al.
Archives of Cardiovascular Diseases|January 7, 2014
Baseline characteristics of patients with heart failure and preserved ejection fraction included in the Karolinska Rennes (KaRen) studyErwan Donal, Lars H Lund, Emmanuel Oger, et al.
Circulation. Heart Failure|June 16, 2017
Significance of Ischemic Heart Disease in Patients With Heart Failure and Preserved, Midrange, and Reduced Ejection Fraction: A Nationwide Cohort StudyOla Vedin, Carolyn S P Lam, Angela S Koh, et al.
Blood Vessels, Thrombosis & Hemostasis|August 6, 2025
Low incidence of thromboembolism with Fiix-monitored warfarin compared to conventional warfarin and DOACs in patients with AFArnar B Ingason, Brynja R Gudmundsdottir, Ragnar Palsson, et al.
Nature Structural & Molecular Biology|January 8, 2025
Importance of an N-terminal structural switch in the distinction between small RNA-bound and free ARGONAUTESimon Bressendorff, Ida Marie Zobbe Sjøgaard, Andreas Prestel, et al.
European Journal of Preventive Cardiology|August 14, 2025
Pharmacological treatment patterns and outcomes according to the coexistence of heart failure and type 2 diabetes: data from the Swedish Heart Failure Registry and National Diabetes RegistryFrancesca Musella, Giulia Ferrannini, Lina Benson, et al.
The American Journal of Medicine|October 18, 2024
Post-Acute COVID-19 Syndrome: Prevalence of Peripheral Microvascular Endothelial Dysfunction and Associations With NT-ProBNP DynamicsMarcus Ståhlberg, Katarina Fischer, Maged Tahhan, et al.
Journal of the American College of Cardiology|January 25, 2023
Worsening Heart Failure: Nomenclature, Epidemiology, and Future Directions: JACC Review Topic of the WeekStephen J Greene, Johann Bauersachs, Jasper J Brugts, et al.
Pageof 83

Showing results (581-590 of 826) with videos related to

Sort By:
Pageof 83
European Journal of Heart Failure|July 22, 2014
Association between cardiovascular vs. non-cardiovascular co-morbidities and outcomes in heart failure with preserved ejection fractionLars H Lund, Erwan Donal, Emmanuel Oger, et al.
Journal of Cardiac Failure|August 27, 2020
Association of Coronary Microvascular Dysfunction With Heart Failure Hospitalizations and Mortality in Heart Failure With Preserved Ejection Fraction: A Follow-up in the PROMIS-HFpEF StudyCamilla Hage, Sara Svedlund, Antti Saraste, et al.
Urology|May 30, 2001
Comparison of the efficacy and safety of finasteride in older versus younger men with benign prostatic hyperplasiaS A Kaplan, H L Holtgrewe, R Bruskewitz, et al.
Archives of Cardiovascular Diseases|January 7, 2014
Baseline characteristics of patients with heart failure and preserved ejection fraction included in the Karolinska Rennes (KaRen) studyErwan Donal, Lars H Lund, Emmanuel Oger, et al.
Circulation. Heart Failure|June 16, 2017
Significance of Ischemic Heart Disease in Patients With Heart Failure and Preserved, Midrange, and Reduced Ejection Fraction: A Nationwide Cohort StudyOla Vedin, Carolyn S P Lam, Angela S Koh, et al.
Blood Vessels, Thrombosis & Hemostasis|August 6, 2025
Low incidence of thromboembolism with Fiix-monitored warfarin compared to conventional warfarin and DOACs in patients with AFArnar B Ingason, Brynja R Gudmundsdottir, Ragnar Palsson, et al.
Nature Structural & Molecular Biology|January 8, 2025
Importance of an N-terminal structural switch in the distinction between small RNA-bound and free ARGONAUTESimon Bressendorff, Ida Marie Zobbe Sjøgaard, Andreas Prestel, et al.
European Journal of Preventive Cardiology|August 14, 2025
Pharmacological treatment patterns and outcomes according to the coexistence of heart failure and type 2 diabetes: data from the Swedish Heart Failure Registry and National Diabetes RegistryFrancesca Musella, Giulia Ferrannini, Lina Benson, et al.
The American Journal of Medicine|October 18, 2024
Post-Acute COVID-19 Syndrome: Prevalence of Peripheral Microvascular Endothelial Dysfunction and Associations With NT-ProBNP DynamicsMarcus Ståhlberg, Katarina Fischer, Maged Tahhan, et al.
Journal of the American College of Cardiology|January 25, 2023
Worsening Heart Failure: Nomenclature, Epidemiology, and Future Directions: JACC Review Topic of the WeekStephen J Greene, Johann Bauersachs, Jasper J Brugts, et al.
Pageof 83